Latest | F'cast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | n/a | 89.5% |
ROCE | 5.6% |
Latest | F'cast | |
---|---|---|
P/E | 10.7 | 7.0 |
PEG | 0.0 | 0.1 |
Pr/Revenue | n/a | 6.5 |
Pr/Book | 0.7 |
Latest | F'cast | |
---|---|---|
Revenue | n/a | n/a |
PBT | 719.6% | 107.4% |
EPS | 331.8% | 92.6% |
DPS | n/a | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-18 | n/a | (0.21) | (0.91)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-19 | n/a | (0.29) | (1.25)p | n/a | n/a | n/a | n/a | 0.0% |
30-Jun-20 | n/a | 0.61 | 0.66p | 8.0 | n/a | n/a | n/a | 0.0% |
30-Jun-21 | n/a | 1.02 | 0.22p | 109.1 | n/a | -67% | n/a | 0.0% |
30-Jun-22 | n/a | 8.36 | 0.95p | 16.8 | 0.1 | +332% | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
30-Jun-23 | 19.38 | 17.34 | 1.83p | 5.6 | 0.1 | +93% | n/a | 0.0% |
Copyright © 2023 FactSet Research Systems Inc. All rights reserved.
Directors’ interests in shares | 15-Mar-2023 | 07:00 | RNS |
Holding(s) in Company | 02-Mar-2023 | 17:50 | RNS |
ANIC invests in Wild Microbes US$3.3m Financing | 23-Feb-2023 | 08:00 | RNS |
No deals were found in the last 28 days.
Currency | UK Pounds |
Share Price | 10.33p |
Change Today | 0.13p |
% Change | 1.23 % |
52 Week High | 22.80 |
52 Week Low | 9.74 |
Volume | 498,893 |
Shares Issued | 992.24m |
Market Cap | £102.45m |
RiskGrade | 475 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 1 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
09:48 | 35,836 @ 10.15p |
09:47 | 50,000 @ 10.00p |
09:47 | 50,000 @ 10.00p |
09:35 | 7,881 @ 10.15p |
09:31 | 19,573 @ 10.15p |
Finance Director | Denham Hervey Newall Eke |
Chair | Richard Reed |
You are here: research